Roble Belko & Company’s ASML ASML Stock Holding History

Roble Belko & Company’s Portfolio ASML Stock Details ASML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$2K	–	449
2025 Q4	$2K	Sell	2 -11	-85%	-$11.5K	﹤0.01%	378
2025 Q3	$13K	Sell	13 -33	-72%	-$25.9K	﹤0.01%	257
2025 Q2	$37K	Sell	46 -1,197	-96%	-$859K	0.01%	194
2025 Q1	$824K	Sell	1,243 -1	-0.1%	-$727	0.13%	60
2024 Q4	$862K	Hold	1,244	–	–	0.14%	60
2024 Q3	$1.04M	Hold	1,244	–	–	0.16%	47
2024 Q2	$1.27M	Buy	1,244 +2	+0.2%	+$1.92K	0.21%	44
2024 Q1	$1.21M	Buy	1,242 +1,241	+124,100%	+$1.1M	0.21%	46
2023 Q4	$1K	Hold	1	–	–	﹤0.01%	295
2023 Q3	$1K	Hold	1	–	–	﹤0.01%	264
2023 Q2	$1K	Hold	1	–	–	﹤0.01%	266
2023 Q1	$1K	Hold	1	–	–	﹤0.01%	270
2022 Q4	$1K	Hold	1	–	–	﹤0.01%	297
2022 Q3	$0	Hold	1	–	–	﹤0.01%	315
2022 Q2	$0	Hold	1	–	–	﹤0.01%	320
2022 Q1	$1K	Hold	1	–	–	﹤0.01%	351
2021 Q4	$1K	Buy	+1	New	+$794	﹤0.01%	320

Other funds holding ASML

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $146B AUM 55.73% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Roble Belko & Company's ASML Position: Q1 2026 in Review

Roble Belko & Company sold out of ASML (ASML) in Q1 2026, closing a stake of 2 shares — an estimated $2K sold.

Roble Belko & Company first reported a position in ASML in Q4 2021 and held it in 17 quarters. The position peaked at $1.27M in Q2 2024. 2,211 funds tracked by Wall St. Rank hold ASML as of Q1 2026.

Roble Belko & Company reported no remaining ASML position as of Q1 2026 after selling out during the quarter.
Roble Belko & Company sold 2 ASML shares in Q1 2026, an estimated $2K.
Roble Belko & Company first reported a position in ASML in Q4 2021 and held it in 17 quarters.
Roble Belko & Company's ASML position peaked at $1.27M in Q2 2024.
2,211 funds tracked by Wall St. Rank held ASML as of Q1 2026.

Based on Roble Belko & Company's 13F filing for Q1 2026, filed 16 Apr 2026.